Coronary vasospasm produces chest pain that closely resembles a heart attack, yet it typically strikes at rest rather than during physical effort, and it tends to come and go in episodes lasting a few minutes before resolving on their own. The pain is caused by a sudden, temporary tightening of one or more coronary arteries, which chokes off blood flow to part of the heart muscle. What makes the condition tricky is that symptoms range from unmistakable crushing chest pressure all the way down to no symptoms at all, with silent episodes of reduced blood flow that the person never feels.
What the Classic Episode Feels Like
The hallmark symptom is squeezing or pressure-like chest pain at rest, often in the early morning hours between midnight and dawn. Unlike the chest pain of a classic blockage, which tends to build during exercise and ease when you stop, vasospastic chest pain shows up when you are doing nothing strenuous. You might be asleep, sitting quietly, or just waking up. The pain can radiate to the left arm, jaw, or shoulder, just as it does in a conventional heart attack, which is part of the reason emergency departments take it seriously.
Episodes are usually brief. The spasm constricts the artery, blood flow drops, and you feel the pain. When the spasm relaxes, blood flow returns and the pain fades, often within two to fifteen minutes. Nitroglycerin, a fast-acting medication that relaxes blood vessel walls, typically relieves the pain within minutes. That rapid response to nitroglycerin is one of the early clinical clues that spasm rather than a fixed blockage is the culprit.
A strong circadian pattern sets vasospasm apart from other forms of chest pain. In one study, exercise tests performed in the early morning triggered attacks in all thirteen patients with variant angina, while the same tests performed in the afternoon provoked attacks in only two of the thirteen.1PubMed. Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: role of exercise-induced coronary arterial spasm That morning vulnerability means you could pass an afternoon stress test with flying colors and still have dangerous spasm episodes at 3 a.m.
When There Is No Pain at All
Not every vasospasm episode announces itself. Silent ischemia, where the heart muscle temporarily loses blood supply without producing any chest pain, is well documented in people with coronary spasm. The ischemia is real and measurable on monitoring equipment, yet the person feels nothing. Research has confirmed that painless episodes occur in variant angina just as they do in other forms of coronary disease, and the absence of pain does not mean the episode is harmless.2PubMed. Role of coronary artery spasm in symptomatic and silent myocardial ischemia Coronary vasospasm can produce a full spectrum of outcomes, from silent ischemia to effort-related chest pain to acute heart attack and even sudden cardiac death.3PubMed Central. Coronary Artery Vasospasm
The silent episodes matter because they can still damage heart muscle over time, and because dangerous heart rhythm disturbances can start during painless ischemia. In one investigation, life-threatening ventricular arrhythmias were triggered during silent ischemic episodes caused by coronary spasm in five patients.4PubMed. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm That finding underscores why treatment focuses on preventing spasm altogether, not just on responding to pain when it appears.
What Happens on an ECG During a Spasm
If you happen to be wearing a heart monitor during an episode, the electrical tracing tells a revealing story. The earliest and most common change is the appearance of tall, peaked, symmetrical T waves, seen in roughly half of patients. If the spasm persists, the tracing progresses to ST-segment elevation, which is the same alarming pattern seen during a full-blown heart attack.5PubMed Central. Prinzmetal angina: ECG changes and clinical considerations: a consensus paper Other changes can include a taller R wave, a shrinking or disappearing S wave, and in about one in five cases, a phenomenon where the ST segment alternates in height and the T wave flips negative.6PubMed Central. Prinzmetal angina: ECG changes and clinical considerations: a consensus paper
The key distinction is that these changes are transient. In a heart attack caused by a blood clot, the ECG abnormalities persist. In vasospasm, the tracing often normalizes within minutes as the artery relaxes. A mild or brief spasm can even produce a completely normal ECG, which is why a single snapshot in the emergency room sometimes misses the diagnosis entirely.7PubMed Central. Coronary Vasospasm Presenting as ST-Elevation Myocardial Infarction Ambulatory ECG monitoring over 24 to 48 hours, which catches those fleeting early-morning episodes, is often more informative than a standard resting ECG.
Serious Complications That Can Follow
Most vasospasm episodes resolve on their own or with medication, but the condition is not benign. Prolonged or severe spasm can fully cut off blood flow long enough to cause actual heart muscle death, meaning a true myocardial infarction. The spasm can also destabilize the heart’s electrical system, triggering dangerous rhythm disturbances including ventricular tachycardia, ventricular fibrillation, and cardiac arrest.8PubMed Central. Coronary artery spasm in cardiac arrest survivors Fatal complications like sudden death, while uncommon with proper treatment, have been documented and are the reason vasospastic angina is taken seriously rather than dismissed as a nuisance.9PubMed Central. Current Evidence on Long-Term Prognostic Factors in Vasospastic Angina
Identifying high-risk patients is an active area of research. When vasospasm causes a heart attack, the outlook depends partly on the type. In one Japanese study, patients who had a heart attack driven by vasospasm had a three-year mortality of about 3.4%, compared with roughly 22% for patients with a different subtype of heart attack not involving spasm, suggesting that spasm-related events may actually carry a somewhat better prognosis when treated.10PubMed Central. Long-Term Prognosis of Patients with Myocardial Infarction Type 1 and Type 2 with and without Involvement of Coronary Vasospasm That relatively favorable outlook depends heavily on the person staying on preventive medication, though.
Triggers and Risk Factors
Cigarette smoking stands out as the single most important modifiable risk factor for vasospastic angina.11PubMed Central. The Smoking Paradox: A Twist in the Tale of Vasospastic Angina Alcohol use is the other substance with a clear, evidence-based association. Clinical studies have found that smoking and alcohol are the only traditional risk factors that show a significant link to triggering spasm; the usual suspects like high blood pressure, high cholesterol, and diabetes are not independently associated with increased spasm risk, even though controlling them is still recommended for overall heart health.12PubMed Central. Management of Coronary Artery Spasm
Other recognized triggers include cold exposure, hyperventilation, emotional stress, and certain drugs. Cocaine is a well-known provocateur of coronary spasm, but the trigger that tends to catch people off guard is a class of migraine medications called triptans. Sumatriptan and related drugs work by constricting blood vessels in the head, but that vasoconstrictive effect is not perfectly limited to the brain. Triptans have been documented as a cause of coronary vasospasm leading to heart attack.13PubMed Central. Vasospasm induced myocardial ischaemia secondary to sumatriptan use In at least one reported case, triptan use caused fatal coronary vasospasm in a young patient who had minimal cardiovascular risk otherwise.14PubMed Central. Fatal coronary vasospasm following oral triptan intake If you have known or suspected vasospastic angina and also get migraines, that is a conversation worth having with your doctor before taking triptans.
Epicardial Versus Microvascular Spasm
Not all coronary spasm looks the same. The form most people and physicians think of involves the large, visible coronary arteries on the heart’s surface, called epicardial arteries. This is the classic variant angina described by Myron Prinzmetal in the 1950s. But spasm can also occur in the tiny arterioles deep within the heart muscle, a condition called coronary microvascular dysfunction. The symptoms overlap, but microvascular spasm tends to produce more diffuse, harder-to-localize discomfort, and the episodes can last longer.
A significant number of people who undergo coronary angiography for chest pain turn out to have normal-looking large arteries and are sent home reassured. Increasing evidence suggests many of these patients actually have microvascular dysfunction or vasospastic angina, and their prognosis is not as benign as they were told. Patients with these conditions face a real increase in the risk of major adverse cardiovascular events, including death.15PubMed Central. Coronary Microvascular Dysfunction and Vasospastic Angina-Pathophysiology, Diagnosis and Management Strategies If you have been told your arteries look fine but you still have recurrent chest pain, asking about vasospasm and microvascular dysfunction testing is reasonable.
How Vasospasm Is Diagnosed
Because the arteries can look perfectly normal between episodes, catching vasospasm in the act usually requires a provocation test. The gold standard is injecting acetylcholine directly into the coronary arteries during a catheterization procedure. Acetylcholine triggers spasm in susceptible arteries while the cardiologist watches on a live X-ray screen. A recent study found that high-dose acetylcholine testing identified spasm in about 79% of patients being evaluated for chest pain with open arteries, with a sensitivity of 98% and a high negative predictive value, meaning a negative result is quite reliable at ruling out significant spasm.16PubMed. Diagnostic Validity of Acetylcholine Provocation Protocols in the Evaluation of Coronary Artery Spasm in Patients With ANOCA
The procedure sounds alarming, but pooled safety data show it is safe. A systematic review estimated the rate of major complications at about 0.5%, with no reported deaths. In Western populations specifically, the complication rate was even lower.17PubMed Central. Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols Despite these reassuring numbers, provocation testing remains underused in many Western cardiology practices, partly because it requires specialized expertise and partly because awareness of vasospastic angina as a diagnosis has historically lagged outside East Asia.
Why the Arteries Go Into Spasm
The underlying mechanism involves an overactive contraction pathway in the smooth muscle cells lining the coronary arteries. An enzyme called Rho-kinase is a central player. When Rho-kinase activity is abnormally elevated, the smooth muscle contracts more forcefully than it should, squeezing the artery down to a fraction of its normal diameter.18PubMed. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina Inflammation can drive this process further, as inflammatory signals increase Rho-kinase activity in human coronary smooth muscle cells.19PubMed. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells Endothelial dysfunction, where the inner lining of the artery fails to produce enough of the relaxation signals that normally keep the vessel open, adds to the problem. The result is an artery that overreacts to ordinary stimuli.
Genetics also play a role. A large genome-wide study identified a specific variant in the gene RNF213 that is strongly associated with vasospastic angina. This variant, found predominantly in East Asian populations, roughly doubles the odds of developing the condition and has also been linked to increased mortality from acute heart attack.20European Medical Journal. Researchers Identify Key Gene Linked to Vasospastic Angina The finding helps explain why vasospastic angina is diagnosed much more frequently in Japan and Korea than in Western countries, though underdiagnosis in the West also accounts for part of the gap.
Conditions That Can Mimic or Overlap With Vasospasm
Because coronary vasospasm produces ST-elevation on an ECG and chest pain, it overlaps with several other conditions in its presentation. The differential diagnosis for chest pain with open coronary arteries, sometimes grouped under the umbrella term MINOCA (myocardial infarction with non-obstructive coronary arteries), includes Takotsubo cardiomyopathy (stress-induced ballooning of the heart), spontaneous coronary artery dissection, focal myocarditis, and pulmonary embolism. Each has distinguishing features, but unraveling them in the emergency room can be challenging.
One unusual mimic worth knowing about is Kounis syndrome, where an allergic reaction triggers coronary spasm. In these cases, the histamine and other mediators released during anaphylaxis or a severe allergic reaction directly provoke the artery to constrict. The symptoms are the same as any other vasospasm episode, but the treatment includes antiallergic therapy alongside the usual cardiac medications.21European Heart Journal – Case Reports. Coronary spasm as a manifestation of allergic reaction to contrast material: a case report of Kounis syndrome If you develop chest pain during or shortly after an allergic reaction, the possibility of allergic coronary spasm should be on the radar.
Treatment and What to Expect on Medication
Calcium channel blockers are the backbone of treatment. These drugs relax the smooth muscle in artery walls, directly counteracting the overactive contraction that causes spasm. Common choices include diltiazem, nifedipine, verapamil, and amlodipine, and at standard doses they fully prevent angina attacks in roughly 80 to 90% of patients.22PubMed Central. Management of Coronary Artery Spasm That is a high success rate, and follow-up studies have shown that keeping spasm under control with these drugs translates into genuinely better long-term outcomes.
A systematic review comparing various calcium channel blockers found that diltiazem reduced the frequency of chest pain and improved quality of life, nifedipine showed clear reductions in angina frequency by four to eight weeks, and amlodipine decreased average weekly chest pain episodes as well.23BMJ. Comparison of various calcium antagonist on vasospastic angina: a systematic review In clinical trials, overall quality of life measured by standardized questionnaires improved significantly after twelve weeks of treatment.24PLOS ONE. Comparison of nebivolol versus diltiazem in improving coronary artery spasm and quality of life in patients with hypertension and vasospastic angina Nitrates, usually long-acting formulations, are often added for patients whose spasm is not fully controlled by a calcium channel blocker alone.
A small minority of patients do not respond adequately to standard drugs. For these refractory cases, research has explored Rho-kinase inhibitors like fasudil, which target the overactive contraction pathway more directly. Continuous low-dose fasudil has shown effectiveness in cases of refractory spasm, particularly during the acute phase after cardiac arrest or reperfusion.25PubMed Central. Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest Fasudil is currently available primarily in Japan and is not widely used in other countries, but it represents an important proof of concept for targeting the underlying mechanism.
The Migraine Connection
People with vasospastic angina sometimes also experience migraine headaches or Raynaud’s phenomenon, the condition where fingers turn white and numb in the cold. This overlap has led researchers to ask whether vasospasm is part of a broader tendency toward exaggerated blood vessel reactivity throughout the body. The evidence is mixed. A Japanese study found that migraine was significantly more common in vasospastic angina patients (23%) than in control groups with other heart conditions (4%) or without heart disease (11%).26Japanese Circulation Journal. Prevalence of Migraine and Raynaud’s Phenomenon in Japanese Patients With Vasospastic Angina A comparable Korean study, however, did not find a significantly higher rate of migraine or Raynaud’s in vasospastic angina patients compared to controls.27PubMed. Does prevalence of migraine and Raynaud’s phenomenon also increase in Korean patients with proven variant angina?
The conflicting results suggest that the relationship between coronary spasm and other vasospastic conditions is real in some populations but not universal. Whether shared genetics, shared environmental triggers, or some combination explains the overlap remains an open question. For practical purposes, if you have vasospastic angina and also get migraines, the overlap is worth mentioning to both your cardiologist and neurologist, especially given the potential for triptans to provoke coronary spasm as noted earlier.
Living With the Diagnosis
One of the most frustrating aspects of vasospastic angina is the gap between the severity of symptoms and what standard testing shows. A person can have terrifying chest pain episodes, arrive at the emergency room, and be told everything looks normal because the spasm has already resolved by the time the ECG is done and the angiogram shows open arteries. Repeated dismissals can lead to real psychological distress and delayed treatment. If your symptoms fit the pattern described here, specifically rest-pain with a preference for early morning, rapid resolution, and relief with nitroglycerin, explicitly asking about vasospasm testing and acetylcholine provocation is a step many patients need to advocate for themselves.
Quitting smoking and limiting alcohol are the two lifestyle changes with the strongest evidence behind them for reducing spasm frequency. Beyond that, staying consistent with calcium channel blocker therapy matters more than almost anything else. Some patients make the mistake of stopping medication once they feel better, not realizing that the drug is preventing spasm rather than curing the underlying tendency. Stopping abruptly can lead to rebound spasm, sometimes worse than the original episodes. The condition tends to wax and wane over years, and some people eventually achieve remission, but the decision to taper medication should be made carefully with a cardiologist familiar with vasospastic angina rather than on your own.